| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 1,880 | 2 | CoC |
Code for the type of first recurrence after a period of documented disease free intermission or remission.
Codes
| 00 | Patient became disease-free after treatment and has not had a recurrence; leukemia in remission. |
| 04 | *In situ* recurrence of an invasive tumor. |
| 06 | *In situ* recurrence of an *in situ* tumor. |
| 10 | Local recurrence and there is insufficient information available to code to 13-17. Recurrence is confined to the remnant of the organ of origin; to the organ of origin; to the anastomosis; or to scar tissue where the organ previously existed. |
| 13 | Local recurrence of an invasive tumor. |
| 14 | Trocar recurrence of an invasive tumor. Includes recurrence in the trocar path or entrance site following prior surgery. |
| 15 | Both local and trocar recurrence of an invasive tumor (both 13 and 14). |
| 16 | Local recurrence of an *in situ* tumor. |
| 17 | Both local and trocar recurrence of an *in situ* tumor. |
| 20 | Regional recurrence, and there is insufficient information available to code to 21-27. |
| 21 | Recurrence of an invasive tumor in adjacent tissue or organ(s) only. |
| 22 | Recurrence of an invasive tumor in regional lymph nodes only. |
| 25 | Recurrence of an invasive tumor in adjacent tissue or organ(s) and in regional lymph nodes (both 21 and 22) at the same time. |
| 26 | Regional recurrence of an *in situ* tumor, NOS. |
| 27 | Recurrence of an *in situ* tumor in adjacent tissue or organ(s) and in regional lymph nodes at the same time. |
| 30 | Both regional recurrence of an invasive tumor in adjacent tissue or organ(s) and/or regional lymph nodes (20-25) and local and/or trocar recurrence (10, 13, 14, or 15). |
| 36 | Both regional recurrence of an *in situ* tumor in adjacent tissue or organ(s) and/or regional lymph nodes (26 or 27) and local and/or trocar recurrence (16 or 17). |
| 40 | Distant recurrence and there is insufficient information available to code to 46-62. |
| 46 | Distant recurrence of an *in situ* tumor. |
| 51 | Distant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid. |
| 52 | Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura. |
| 53 | Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid. |
| 54 | Distant recurrence of an invasive tumor in the liver only. |
| 55 | Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site. |
| 56 | Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye. |
| 57 | Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site. |
| 58 | Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site. |
| 59 | Distant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, and generalized disease. |
| 60 | Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar, and/or regional recurrence (10-15, 20-25, or 30). |
| 62 | Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59). |
| 70 | Since diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated. |
| 88 | Disease has recurred, but the type of recurrence is unknown. |
| 99 | It is unknown whether the disease has recurred or if the patient was ever disease-free. |